封面
市场调查报告书
商品编码
1619172

伴同性动物诊断市场规模、份额、成长分析、按技术、按动物类型、按应用、按最终用户、按地区 - 行业预测,2024-2031 年

Companion Animal Diagnostics Market Size, Share, Growth Analysis, By Technology (Clinical biochemistry, Immunodiagnostics), By Animal Type (Dogs, Cats), By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年,伴同性动物诊断的全球市场规模为23亿美元,从2023年的25.3亿美元增长到2031年的53.4亿美元,在预测期内(2024-2031年)预计将以复合年增长率增长。 9.8%。

宠物慢性病盛行率的上升和诊断技术的进步预计将推动伴同性动物诊断市场的显着成长。据报道,从2012年到2022年,狗的糖尿病将增加40%,猫的糖尿病将增加30%,迫切需要有效的诊断。宠物拥有量的增加进一步推动了这个市场,超过 6,390 万家庭拥有至少一隻狗,约 5,200 万个家庭拥有一隻猫。此外,对自动化和半自动化诊断测试的需求正在迅速增加,从而提高了样品处理的效率。护理点诊断 (POCD) 等创新有望快速取得成果,而旨在改善兽医服务的政府倡议将支持长期市场扩张。到 2031 年,美国的动物保健费用预计将达到 330 亿美元。

目录

介绍

  • 研究目的
  • 调查范围
  • 定义

调查方法

  • 资讯采购
  • 二手资料和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 抑制因素和挑战
  • 波特分析与影响
    • 竞争公司之间的敌对关係
    • 替代品的威胁
    • 买方议价能力
    • 新进入者的威胁
    • 供应商的议价能力

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2023)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 价格分析
  • 技术进步
  • 监管环境
  • 案例研究

伴同性动物诊断市场规模:依技术分类

  • 市场概况
  • 临床生物化学
    • 临床化学分析
    • 试剂夹盒
    • 分析仪
    • 血糖监测
    • 血糖值测试纸
    • 血糖值监测仪
    • 尿糖测试纸
    • 血气电解质分析
    • 试剂夹盒
    • 血气/电解质分析仪
  • 免疫诊断
    • 横向流动化验
    • 快速测试
    • 条带龙头(侧向流读取仪)
    • 酵素连结免疫吸附试验
    • 过敏特异性免疫诊断测试
    • 免疫检测分析仪
    • 其他免疫诊断动物类型
  • 血液学
    • 墨水匣
    • 分析仪
  • 尿液检查
    • 夹子和墨盒/面板
    • 尿液分析仪
    • 尿液检查纸条
  • 分子诊断
    • 聚合酵素链锁反应测试
    • 微阵列
    • 其他分子诊断动物物种
  • 其他宠物诊断技术

伴同性动物诊断市场规模:依动物类型

  • 市场概况
  • 其他宠物

伴同性动物诊断市场规模:依应用分类

  • 市场概况
  • 临床病理学
  • 细菌学
  • 病毒学
  • 寄生虫学
  • 其他用途

伴同性动物诊断市场规模:依最终用户划分

  • 市场概况
  • 诊断实验室
  • 动物医院/诊所
  • 研究机构和大学
  • 居家照护设置

伴同性动物诊断市场规模:按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东/非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲

竞争资讯

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2023)
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分類的份额分析
    • 收益与前一年同期比较(2021-2023)

主要企业简介

  • Idexx Laboratories, Inc.
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc.
  • Biomerieux SA
  • Virbac
  • Neogen Corporation
  • Fujifilm Holdings Corporation
  • Indical Bioscience GmbH
  • Idvet
  • Randox Laboratories, Ltd.
  • Bionote, Inc.
  • Skyla Corporation
  • Urit Medical Electronic Co., Ltd.
  • Nova Biomedical
  • Fassisi GmbH
  • Swissavans AG
  • Alvedia
  • Megacor Veterinary Diagnostics
  • Biopanda Reagents Ltd
  • Anipoc Ltd
  • Ring Biotechnology Co Ltd.

结论和建议

简介目录
Product Code: SQMIG35D2047

Global Companion Animal Diagnostics Market size was valued at USD 2.3 billion in 2022 and is poised to grow from USD 2.53 billion in 2023 to USD 5.34 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031).

The growing prevalence of chronic disorders in pets, coupled with advancements in diagnostics, is poised to drive significant growth in the companion animal diagnostics market. Reports indicate a staggering 40% rise in canine diabetes and a 30% increase in feline diabetes from 2012 to 2022, reflecting an urgent need for effective diagnostics. The rising number of pet owners further supports this market, with over 63.9 million households owning at least one dog and around 52 million with cats. Additionally, the demand for automated and semi-automated diagnostic testing is surging, enhancing efficiency in sample handling. Innovations such as Point of Care Diagnostics (POCD) promise expedited results, while government initiatives aimed at improving veterinary services underpin long-term market expansion. The U.S. veterinary care expenditure is expected to reach USD 33 billion by 2031.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Diagnostics Market Segmental Analysis

Global Companion Animal Diagnostics Market is segmented by Technology, Animal Type, Application, End User, and region. Based on Technology, the market is segmented into Clinical biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecularity Molecular diagnostics, and Other Companion Animal Diagnostic Technologies. Based on Animal Type, the market is segmented into Dogs, Cats, Horses, and Other companion animals. Based on Application, the market is segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, and Other Applications. Based on End User, the market is segmented into Diagnostic Laboratories, Veterinary Hospitals & Clinics, Research Institutes & Universities, and Home-care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Companion Animal Diagnostics Market

The Global Companion Animal Diagnostics market is witnessing significant growth driven by the increasing demand for rapid testing and portable diagnostic tools designed for point-of-care (PoC) services. These tools have become essential for veterinarians, facilitating the quick detection of animal illnesses, particularly in remote locations like homes or shelters, and during emergencies. Major manufacturers are focusing on developing innovative portable diagnostics that enhance workflow in veterinary hospitals and research institutions. Additionally, pet healthcare spending, including veterinary treatments and pet insurance, has surged, encouraging pet owners, especially in North America and Europe, to invest in comprehensive care for their animals. This surge in demand for efficient, cost-effective diagnostic solutions underpins the expansion of the market.

Restraints in the Global Companion Animal Diagnostics Market

The growth of the Global Companion Animal Diagnostics market may be hindered by escalating pet care expenses, particularly in developing nations where there is a shortage of veterinarians. These rising costs could deter pet owners from seeking necessary diagnostic services, ultimately impacting market expansion. Additionally, a general lack of awareness regarding animal healthcare poses a substantial challenge, preventing pet owners from recognizing the importance of regular diagnostics. Collectively, these factors will likely create significant obstacles for the companion animal diagnostics market during the projected period, impeding its potential for growth and advancement.

Market Trends of the Global Companion Animal Diagnostics Market

The Global Companion Animal Diagnostics market is witnessing a significant trend driven by heightened research and development efforts focused on the diagnostic capabilities for companion animals, especially in relation to SARS-CoV-2 exposure. As various animal species emerge as potential vectors for COVID-19, key health organizations, including the CDC and USDA, are actively engaging in monitoring and studying these vulnerabilities. This surge in research not only enhances understanding of the epidemiological impact on animal and human health but also stimulates innovation in diagnostic devices. Consequently, the market is anticipated to expand, reflecting an increased demand for advanced diagnostic solutions that ensure better health outcomes for companion animals.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies

Global Companion Animal Diagnostics Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • Clinical biochemistry
    • Clinical chemistry analysis
    • Reagents, clips, and cartridges
    • Analyzers
    • Glucose monitoring
    • Blood glucose strips
    • Glucose monitors
    • Urine glucose strips
    • Blood gas electrolyte analysis
    • Reagents, clips, and cartridges
    • Blood gas & electrolyte analyzers
  • Immunodiagnostics
    • Lateral flow assays
    • Rapid tests
    • Strip readers (Lateral flow readers)
    • Elisa tests
    • Allergen-specific immunodiagnostic tests
    • Immunoassay analyzers
    • Other immunodiagnostic Animal Types
  • Hematology
    • Cartridges
    • Analyzers
  • Urinalysis
    • Clips & cartridges/panels
    • Urine Analyzers
    • Urine test strips
  • Molecular diagnostics
    • Polymerase chain reaction tests
    • Microarrays
    • Other molecular diagnostic Animal Types
  • Other Companion Animal Diagnostic Technologies

Global Companion Animal Diagnostics Market Size by Animal Type & CAGR (2024-2031)

  • Market Overview
  • Dogs
  • Cats
  • Horses
  • Other companion animals

Global Companion Animal Diagnostics Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Clinical Pathology
  • Bacteriology
  • Virology
  • Parasitology
  • Other Applications

Global Companion Animal Diagnostics Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Diagnostic Laboratories
  • Veterinary Hospitals & Clinics
  • Research Institutes & Universities
  • Home-care Settings

Global Companion Animal Diagnostics Market Size & CAGR (2024-2031)

  • North America (Technology, Animal Type, Application, End User)
    • US
    • Canada
  • Europe (Technology, Animal Type, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Technology, Animal Type, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Technology, Animal Type, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Technology, Animal Type, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Idexx Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoetis Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerieux SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Indical Bioscience GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Idvet
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories, Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bionote, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Skyla Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Urit Medical Electronic Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nova Biomedical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fassisi GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Swissavans AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alvedia
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Megacor Veterinary Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biopanda Reagents Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anipoc Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ring Biotechnology Co Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation